TQB2934 not checked

Chia Tai Tianqing Pharmaceutical Group Co., Ltd.

FollowEvery change as it happens, and a Monday email
Stage
 
Next date
Phase 3 trial completes
Trials
3 active
4 in total
Targets
 

What this is

How it works
How it works isn't classified yet
How it’s given
“TQB2934 injection is a bispecific antibody targeting B-cell maturation antigen (BCMA) and Cluster of Differentiation 3 (CD3).”In the company’s words, NCT07569757 on ClinicalTrials.gov
Tested for
Multiple Myeloma (2 trials), Systemic Light Chain Amyloidosis
Main trialPhase 3
“This study is a randomized, open-label, multicenter Phase III clinical trial involving patients with relapsed/refractory multiple myeloma. The estimated total sample size is 260 cases, who will be randomly assigned in a 1:1 ratio to the test group and the control group. The primary objective of the study is to demonstrate the efficacy of TQB2934 for injection compared to the investigator-selected regimen in subjects with relapsed or refractory multiple myeloma (RRMM) by evaluating progression-free survival (PFS).”In the company’s words, NCT07569757 on ClinicalTrials.gov

Other drugs for Multiple Myeloma

All 133 drugs for Multiple Myeloma

Coming up3

Changes0

Last 90 days

No changes yet. We started recording changes on 6 Nov 2026.

Trials4

TrialPhaseCompletesWhat it tests
Phase 3Not yet recruiting Dec 2028 Clinical Study of TQB2934 Injection in Relapsed/Refractory Multiple Myeloma
Phase 1/2Recruiting Feb 2029 Assessment of the Efficacy and Safety of Injectable TQB2934 (Subcutaneous Injection) in Systemic Light Chain Amyloidosis Patients
Phase 1Recruiting Oct 2027 A Clinical Study Assessing the Subcutaneous Formulation of TQB2934 for Injection in Subjects With Malignant Plasma Cell Tumors
Phase 1Unknown Oct 2024 A Clinical Trial of TQB2934 for Injection in Multiple Myeloma Subjects
A trial in both registries shows both numbers.

About

Sources
ClinicalTrials.gov updated 18 Nov 2026 · EU trials register (CTIS) updated 18 Nov 2026 · openFDA updated 17 Nov 2026

Follow TQB2934

Following is part of Solo: you see every change to TQB2934 the day it happens.

Solo

$49a month, excl. VAT

  • Follow up to 5 landscapes, companies or drugs
  • Every change, the day it happens
  • A Monday email with the week’s changes
Choose Solo

Free

$0no card

  • One landscape of your own, in full
  • The top 10 of everything else
Sign up free

Have an account? Sign in